BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 33931980)

  • 1. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer.
    Chen Y; Zitello E; Guo R; Deng Y
    Clin Transl Med; 2021 Apr; 11(4):e367. PubMed ID: 33931980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].
    Sestini S; Boeri M; Marchianò A; Silva M; Calareso G; Galeone C; Sozzi G; Pastorino U
    Epidemiol Prev; 2016; 40(1 Suppl 1):42-50. PubMed ID: 26951732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
    Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
    Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
    Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer.
    Liu C; Xiang X; Han S; Lim HY; Li L; Zhang X; Ma Z; Yang L; Guo S; Soo R; Ren B; Wang L; Goh BC
    Cancer Lett; 2022 Jan; 524():91-102. PubMed ID: 34656690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
    Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
    Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
    Tantai J; Hu D; Yang Y; Geng J
    Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
    Sozzi G; Boeri M; Rossi M; Verri C; Suatoni P; Bravi F; Roz L; Conte D; Grassi M; Sverzellati N; Marchiano A; Negri E; La Vecchia C; Pastorino U
    J Clin Oncol; 2014 Mar; 32(8):768-73. PubMed ID: 24419137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis.
    Aftabi Y; Ansarin K; Shanehbandi D; Khalili M; Seyedrezazadeh E; Rahbarnia L; Asadi M; Amiri-Sadeghan A; Zafari V; Eyvazi S; Bakhtiyari N; Zarredar H
    IUBMB Life; 2021 Feb; 73(2):307-327. PubMed ID: 33369006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor-tyrosine kinase inhibitor therapy.
    Lv P; Yang S; Liu W; Qin H; Tang X; Wu F; Liu Z; Gao H; Liu X
    Thorac Cancer; 2020 Jan; 11(1):29-40. PubMed ID: 31691525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: A phantom study.
    Perisinakis K; Seimenis I; Tzedakis A; Karantanas A; Damilakis J
    Eur Radiol; 2018 Oct; 28(10):4370-4378. PubMed ID: 29651767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress regarding long-chain non-coding RNA in lung cancer: a narrative review.
    Yu P; He X; Lu F; Li L; Song H; Bian X
    J Thorac Dis; 2022 Aug; 14(8):3016-3029. PubMed ID: 36071788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
    Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
    Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of long noncoding RNAs for the detection of early stage lung squamous cell carcinoma by microarray analysis.
    Cheng Z; Bai Y; Wang P; Wu Z; Zhou L; Zhong M; Jin Q; Zhao J; Mao H; Mao H
    Oncotarget; 2017 Feb; 8(8):13329-13337. PubMed ID: 28076325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
    McCunney RJ; Li J
    Chest; 2014 Mar; 145(3):618-24. PubMed ID: 24590022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
    Wang X; Zhi X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Shen D; Zheng C; Zhao D; Yang S; Qi J; Xin H; Stojadinovic A; Avital I; Lee LJ; Rao J; Zhang W
    Oncotarget; 2017 Jul; 8(28):45345-45355. PubMed ID: 28514755
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.